Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2025-12-27 @ 5:31 AM
Study NCT ID:
NCT00388960
Status:
COMPLETED
Last Update Posted:
2019-11-19
First Post:
2006-10-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-11-01
Start Date Type:
ACTUAL
Primary Completion Date:
2010-04-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-12-01
Completion Date Type:
ACTUAL
First Submit Date:
2006-10-13
First Submit QC Date:
None
Study First Post Date:
2006-10-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-06-05
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2019-11-14
Last Update Post Date:
2019-11-19
Last Update Post Date Type:
ACTUAL